Secondary Logo

Journal Logo

Articles by Dario Cattaneo, MD

A Comparison of Tenofovir Predose Concentrations in Generic Pre-exposure Prophylaxis Formulations: A Short Communication

Cattaneo, Dario; Gervasoni, Cristina; Vinti, Pietro; More

Therapeutic Drug Monitoring. 42(4):643-647, August 2020.

Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data

Daskapan, Alper; Tran, Quynh T.D.; Cattaneo, Dario; More

Therapeutic Drug Monitoring. 41(1):59-65, February 2019.

Effect of N-Desalkylquetiapine/Quetiapine Plasma Level Ratio on Anxiety and Depression in Bipolar Disoder: A Prospective Observational Study

Rovera, Chiara; Mauri, Massimo C.; Chiara, Di Pace; More

Therapeutic Drug Monitoring. 39(4):441-445, August 2017.

Pharmacokinetics and Pharmacogenetics of Selective Serotonin Reuptake Inhibitors During Pregnancy: An Observational Study

Pogliani, Laura; Falvella, Felicia S.; Cattaneo, Dario; More

Therapeutic Drug Monitoring. 39(2):197-201, April 2017.

Comparison of the In Vivo Pharmacokinetics and In Vitro Dissolution of Branded Versus Generic Efavirenz Formulation in HIV-Infected Patients

Gervasoni, Cristina; Baldelli, Sara; Cerea, Matteo; More

Therapeutic Drug Monitoring. 38(3):420-422, June 2016.

Comparison of the Pharmacokinetics of Raltegravir Given at 2 Doses of 400 mg by Swallowing Versus One Dose of 800 mg by Chewing in Healthy Volunteers: A Randomized, Open-Label, 2-Period, Single-Dose, Crossover Phase 1 Study

Cattaneo, Dario; Cossu, Maria V.; Fucile, Serena; More

Therapeutic Drug Monitoring. 37(1):119-125, February 2015.